Insider Stock Trading History of Berkman Charles S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Berkman Charles S since year 2005. The trader's CIK number is 1392266. At the time of this reporting, Berkman Charles S is the VP, Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc . (stock ticker symbol LGND). See this page for all insider trading activities at Ligand Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Berkman Charles S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-09 LGND Ligand Pharmaceuticals Inc Sale 18,625 126.96 2,364,667
2015-07-10 LGND Ligand Pharmaceuticals Inc Sale 14,067 99.06 1,393,519
2015-07-13 LGND Ligand Pharmaceuticals Inc Option Ex 1,000 53.10 53,100
2015-07-10 LGND Ligand Pharmaceuticals Inc Option Ex 14,067 12.26 172,461
2015-03-16 LGND Ligand Pharmaceuticals Inc Option Ex 5,264 18.20 95,778
2015-03-16 LGND Ligand Pharmaceuticals Inc Sale 11,264 74.56 839,810
2014-12-31 LGND Ligand Pharmaceuticals Inc Buy 126 45.23 5,698
2014-06-30 LGND Ligand Pharmaceuticals Inc Buy 329 43.79 14,407
2014-05-27 LGND Ligand Pharmaceuticals Inc Sale 7,166 66.92 479,548
2014-05-27 LGND Ligand Pharmaceuticals Inc Option Ex 2,499 15.45 38,609
2014-02-12 LGND Ligand Pharmaceuticals Inc Sale 14,881 74.50 1,108,634
2014-02-12 LGND Ligand Pharmaceuticals Inc Option Ex 14,881 19.49 290,045
2014-02-13 LGND Ligand Pharmaceuticals Inc Option Ex 2,000 14.47 28,940
2013-12-31 LGND Ligand Pharmaceuticals Inc Buy 209 33.91 7,088
2013-08-30 LGND Ligand Pharmaceuticals Inc Option Ex 37,331 16.47 614,729
2013-08-30 LGND Ligand Pharmaceuticals Inc Sale 28,323 47.54 1,346,447
2013-08-19 LGND Ligand Pharmaceuticals Inc Option Ex 4,284 10.05 43,054
2013-08-16 LGND Ligand Pharmaceuticals Inc Sale 14,583 42.63 621,731
2013-08-16 LGND Ligand Pharmaceuticals Inc Option Ex 14,583 9.96 145,246
2013-06-28 LGND Ligand Pharmaceuticals Inc Buy 815 17.36 14,148
2013-05-10 LGND Ligand Pharmaceuticals Inc Sale 4,000 26.66 106,640
2012-09-07 LGND Ligand Pharmaceuticals Inc Sale 4,249 18.77 79,753
2012-03-08 LGND Ligand Pharmaceuticals Inc Sale 3,606 15.76 56,841
2011-02-16 LGND Ligand Pharmaceuticals Inc Sale 5,000 9.75 48,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berkman Charles S (VP, Gen. Counsel & Secretary of Ligand Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.